Maravai Lifesciences Holdings (MRVI) EBT Margin Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | 10,255.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,255.00 |
| Dec 31, 2025 | -4,489.00 |
| Sep 30, 2025 | 14,094.00 |
| Jun 30, 2025 | -12,635.00 |
| Mar 31, 2025 | -7,755.00 |
| Dec 31, 2024 | -96,651.00 |
| Sep 30, 2024 | -21,864.00 |
| Jun 30, 2024 | -1,065.00 |
| Mar 31, 2024 | -2,919.00 |
| Dec 31, 2023 | 83,822.00 |
| Sep 30, 2023 | -9,023.00 |
| Jun 30, 2023 | -9,148.00 |
| Mar 31, 2023 | -7,402.00 |
| Dec 31, 2022 | -1,650.00 |
| Sep 30, 2022 | -1,426.00 |
| Jun 30, 2022 | 510.00 |
| Mar 31, 2022 | 813.00 |
| Dec 31, 2021 | 4,825.00 |
| Sep 30, 2021 | 2,973.00 |
| Jun 30, 2021 | 6,554.00 |